Novel trans-3,5-disubstituted pyrrolidinylthio-1 beta-methylcarbapenems wer
e designed and synthesized to provide J-111,347 (la) as the first example o
f an exceptionally broad-spectrum antibiotic, showing activity against meth
icillin-resistant Sta-phyloccocus aureus (MRSA) phyloccocus aureus (MRSA) a
s well as Pseudomonas aeruginosa. Further derivation of 1a afforded J-111,2
25 (2a), J-114,870 (3a), and J-114,871 (3b), which showed improved safety p
rofiles and retained broad-spectrum antibacterial activities. (C) 2000 Else
vier Science Ltd. All rights reserved.